Wuxi Kejin Biotechnology Co.

BiotechnologyAngelWuxi, China

Latest round

Angel

Last raised

Feb 2022

Total raised

$16M

Investors

3

About Wuxi Kejin Biotechnology Co.

, Ltd is a biotechnology company that focuses on the research, development and production of anticancer drugs. The company's founder and CEO, Dr. Haifeng Wang, was in charge of market development in the Wuxi App Tec. The company's co-founder and Chief Scientific Officer, Prof. Jose Carlos Segovia, also works at the CIEMAT in Spain. He has applied for five orphan drugs.0. Combines with the AAV (adeno-associated viral vector) delivery system, the gene editing efficiency can reach 70%. It can also avoid the risk of CRISPR off-target and various immunological and oncogenic risks of AAV entering the body. The company is working on the development of cellular therapeutics for pyruvate kinase deficiency (PKD) and other rare diseases of the blood. The PKD pipeline is expected to complete IND filings in China and Europe in 2023.

Who invested in Wuxi Kejin Biotechnology Co.

3 investors across 1 round

See all investors in Wuxi Kejin Biotechnology Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    Feb 28, 2022

    Amount

    $16M

    Investors

    Locked

Questions about Wuxi Kejin Biotechnology Co.

Who invested in Wuxi Kejin Biotechnology Co.?

Wuxi Kejin Biotechnology Co. has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Wuxi Kejin Biotechnology Co. raised?

Wuxi Kejin Biotechnology Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Wuxi Kejin Biotechnology Co. last raise money?

Wuxi Kejin Biotechnology Co.'s most recent round on record is a Angel, in Feb 2022.

What does Wuxi Kejin Biotechnology Co. do?

, Ltd is a biotechnology company that focuses on the research, development and production of anticancer drugs.

Where is Wuxi Kejin Biotechnology Co. headquartered?

Wuxi Kejin Biotechnology Co. is headquartered in Wuxi, China.

Which VCs invest in companies like Wuxi Kejin Biotechnology Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Wuxi Kejin Biotechnology Co.'s stage. Their profiles are linked below.

Raising like Wuxi Kejin Biotechnology Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.